Bourgeon Capital Management’s Regulus Therapeutics RGLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-32
| Closed | – | – | 304 |
|
|
2020
Q4 | $0 | Hold |
32
| – | – | ﹤0.01% | 317 |
|
|
2020
Q3 | $0 | Hold |
32
| – | – | ﹤0.01% | 315 |
|
|
2020
Q2 | $0 | Hold |
32
| – | – | ﹤0.01% | 271 |
|
|
2020
Q1 | $0 | Hold |
32
| – | – | ﹤0.01% | 272 |
|
|
2019
Q4 | $0 | Hold |
32
| – | – | ﹤0.01% | 243 |
|
|
2019
Q3 | $0 | Buy |
+32
| New | – | ﹤0.01% | 239 |
|
|
2018
Q3 | – | Sell |
-111
| Closed | -$9K | – | 77 |
|
|
2018
Q2 | $9K | Hold |
111
| – | – | ﹤0.01% | 73 |
|
|
2018
Q1 | $10K | Sell |
111
-479
| -81% | -$43.2K | 0.01% | 74 |
|
|
2017
Q4 | $74K | Buy |
590
+250
| +74% | +$31.4K | 0.04% | 86 |
|
|
2017
Q3 | $51K | Buy |
+340
| New | +$51K | 0.03% | 88 |
|
|
2017
Q1 | – | Sell |
-199
| Closed | -$54K | – | 100 |
|
|
2016
Q4 | $54K | Sell |
199
-178
| -47% | -$48.3K | 0.03% | 92 |
|
|
2016
Q3 | $149K | Sell |
377
-212
| -36% | -$83.8K | 0.1% | 86 |
|
|
2016
Q2 | $204K | Buy |
589
+211
| +56% | +$73.1K | 0.13% | 81 |
|
|
2016
Q1 | $314K | Buy |
378
+122
| +48% | +$101K | 0.21% | 69 |
|
|
2015
Q4 | $268K | Sell |
256
-119
| -32% | -$125K | 0.17% | 72 |
|
|
2015
Q3 | $294K | Buy |
375
+206
| +122% | +$162K | 0.21% | 76 |
|
|
2015
Q2 | $222K | Hold |
169
| – | – | 0.13% | 98 |
|
|
2015
Q1 | $343K | Buy |
+169
| New | +$343K | 0.21% | 83 |
|